This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poirel, L.
Right arrow Articles by Nordmann, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poirel, L.
Right arrow Articles by Nordmann, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2008, p. 1252-1256, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.01304-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp.{triangledown}

Laurent Poirel,1 Samy Figueiredo,1 Vincent Cattoir,1 Alessandra Carattoli,2 and Patrice Nordmann1*

Service de Bactériologie-Virologie, INSERM U914, Emerging Resistance to Antibiotics, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Université Paris XI, Le Kremlin-Bicêtre, France,1 Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanita, Rome, Italy2

Received 10 October 2007/ Returned for modification 14 November 2007/ Accepted 4 January 2008


arrow
ABSTRACT
 
Carbapenem resistance results mostly from the expression of acquired carbapenem-hydrolyzing oxacillinases in Acinetobacter baumannii. The blaOXA-23 oxacillinase gene is increasingly reported worldwide and may represent an emerging threat. Our goal was to identify the progenitor of that carbapenemase gene. A collection of 50 Acinetobacter sp. strains corresponding to several Acinetobacter species was screened for blaOXA-23-like genes by PCR and hybridization techniques. Five Acinetobacter radioresistens isolates that were susceptible to carbapenems harbored chromosomally encoded blaOXA-23-like genes. A similar plasmid backbone was identified in several blaOXA-23-positive A. baumannii and A. radioresistens isolates, further strengthening the vectors of exchanges for these blaOXA-23-like genes. Therefore, A. radioresistens, a commensal bacterial species which is identified on the skin of hospitalized and healthy patients (a property shared with A. baumannii), was identified as the source of the blaOXA-23 gene.


arrow
INTRODUCTION
 
Carbapenem resistance in Acinetobacter baumannii is increasingly reported and leads to difficult-to-treat nosocomial infections (25, 28, 33, 38). Carbapenem-hydrolyzing class D β-lactamases (CHDLs) represent the main mechanism of resistance to carbapenems in Acinetobacter spp. (4, 25). Three main groups of acquired CHDLs have been identified in A. baumannii and are of the OXA-23, OXA-40, and OXA-58 types. These oxacillinases confer reduced susceptibility or resistance to carbapenems once they are expressed in A. baumannii (13). Several studies have reported that those oxacillinase genes are encoded by transferable plasmids and likely possess restricted host ranges since attempts to transfer the oxacillinase genes from A. baumannii to Escherichia coli as the recipient strain failed (3, 13, 32). The β-lactamase OXA-23 (formerly ARI-1) was identified first in Scotland and was found to be a source of transferable resistance to imipenem in A. baumannii (10). Since then, OXA-23 producers have been identified as sources of nosocomial outbreaks worldwide, including Brazil, Colombia, the United Kingdom, Korea, Tahiti, and China (6, 9, 19, 23, 40, 42, 44). In addition, OXA-23-producing and carbapenem-resistant Acinetobacter sp. isolates have been isolated from soldiers with infections returning from Iraq and are a possible source of further spread in the United States and the United Kingdom (15, 20). The origin (reservoir) of those CHDL genes remains unknown.

Recently, we identified acquired blaOXA-23 genes located in peculiar transposon structures, namely, Tn2006 (ISAba1 linked) and Tn2007 (ISAba4 linked) from carbapenem-resistant A. baumannii isolates (7). The Tn2006 structure consists of two copies of the same ISAba1 insertion sequence bracketing the blaOXA-23 gene together with an ATPase-encoding gene (Fig. 1) (7). Transposon Tn2007 contains a single copy of ISAba4 associated with the same ATPase-encoding gene located downstream of the blaOXA-23 gene (7). This ATPase-encoding gene has been identified in 13 of 13 blaOXA-23-positive A. baumannii isolates studied (7).


Figure 1
View larger version (11K):
[in this window]
[in a new window]

  		FIG. 1. Schematic maps of composite transposon Tn2006 carrying the blaOXA-23 gene identified on a plasmid in A. baumannii isolates (7) (A) and the sequences identified in the five different A. radioresistens isolates (B). The sequences identical between Tn2006, Tn2007, and the A. radioresistens isolates are indicated by two vertical lines. ATPase is the gene encoding the putative ATPase, and sulf is the gene for a plasmid-borne sulfonamide resistance gene truncated by the insertion of Tn2006. orf1 is the gene encoding a putative protein truncated by the insertion of Tn2007, and mobA is the gene encoding a putative mobilization protein. Sequences indicated by dashes are unknown.

Therefore, considering that the blaOXA-23 gene (i) has mostly been identified in Acinetobacter spp., (ii) has a GC content of 38% (which fits with that of the Acinetobacter sp. genes [12, 37]), (iii) was associated with a gene encoding an AAA ATPase that shared a high degree of identity with that of another related species (Acinetobacter baylyi [1]), and (iv) was likely mobilized by the ISAba1 insertion sequence that is widespread in Acinetobacter spp. (14, 35), we hypothesized that the blaOXA-23 gene may originate from a species possibly belonging to the genus Acinetobacter. In addition, we hypothesized that the donor of the gene may share the same reservoir as the recipient A. baumannii isolate, i.e., the human skin. This prompted us to search for the progenitor of this emerging carbapenemase gene.


arrow
MATERIALS AND METHODS
 
Bacterial strains and patients. Our screening panel included 50 Acinetobacter sp. strains that belonged to 14 different Acinetobacter species, including A. junii; A. johnsonii; A. haemolyticus; A. baylyi; A. lwoffii; A. radioresistens; A. schindleri; A. ursingii; and Acinetobacter genomospecies 3, 10, 13, 15, 16, and 17. Those strains were identified to the species level by using molecular techniques, as described by Dortet et al. (11). Reference strain A. radioresistens CIP103788 was from a cotton plant from Argentina (24). Four additional A. radioresistens strains were from skin and urinary tract specimens of patients from the Hôpital de Bicêtre (data not shown). blaOXA-23-positive A. baumannii strain Ab13 was used as a control for the molecular experiments and the biochemical assays (7).

Molecular techniques. A PCR-based screening for the blaOXA-23 gene was performed with primers OXA-IMP1 and OXA-IMP2 (Table 1) (13). The AAA ATPase-encoding gene was amplified with primer ATPaseB3 (Table 1) in combination with primer OXA-IMP1 (13). The screening for insertion sequences ISAba1 and ISAba4 was performed with primers ISAba1A and ISAba1B and primers ISAba4A and ISAba4B, respectively (Table 1). The chromosomal location of the blaOXA-23 gene was demonstrated by using the endonuclease I-Ceu-I technique, as described previously (21). Briefly, analysis of the I-Ceu-I-restricted fragments of whole-cell DNAs of the A. radioresistens isolates was performed by pulsed-field gel electrophoresis (PFGE) and gave five DNA fragments in each case. Then, transfer and Southern hybridization were performed as described previously (29, 34) with DNA probes specific for rRNA, consisting of a 1,504-bp PCR fragment specific for 16S rRNA genes (22) and a 840-bp internal PCR fragment specific for the blaOXA-23 gene.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Sequences of primers used in the study

Cloning of the entire blaOXA-23-like genes (amplified with primers PreOXA-23A and PreOXA-23B [Table 1]) was performed by using kanamycin-resistant plasmid pCR-BluntII-TOPO (Invitrogen, Life Technologies, Cergy-Pontoise, France), and the recombinant plasmids were transferred into E. coli TOP10 (Invitrogen). The selection of recombinant clones was done with plates containing kanamycin (30 µg/ml) and amoxicillin (30 µg/ml). The sequences of the cloned fragments were confirmed by double-strand sequencing.

Culture media and susceptibility testing. The A. baumannii and A. radioresistens strains were grown on Mueller-Hinton agar plates and incubated overnight at 37°C. The MICs of the antibiotics were determined by Etest (AB Biodisk, Solna, Sweden) on Mueller-Hinton agar plates at 37°C. Carbapenemase activities were assayed by UV spectrophotometry with culture extracts of the A. radioresistens isolates obtained as described and with 100 µM benzylpenicillin or imipenem as the substrate (31). One unit of activity was defined as the amount of enzyme hydrolyzing 1 µmol of substrate per min per mg of protein.

Plasmid analysis. Since the repAci1 gene encoding a novel replicase was recently identified from a plasmid carrying the gene encoding another CHDL (OXA-58) from an A. baumannii isolate, PCR was used to search for it among the blaOXA-23-positive A. baumannii isolates and A. radioresistens strains by using primers RepAFW and RepARV (Table 1) (3). The specificity of the repAci1 PCR assay was confirmed by subsequent sequencing of the amplicons obtained from the A. baumannii and the A. radioresistens strains. The aim of that experiment was to determine whether plasmids circulating in A. baumannii could be also identified in A. radioresistens and whether they could thus be possible vehicles for gene exchanges between both species.

Nucleotide sequence accession number. The nucleotide sequences of the blaOXA-23-like genes from A. radioresistens have been deposited in the GenBank database under accession number EU131372.


arrow
RESULTS
 
Identification of progenitor. A preliminary PCR screening gave a blaOXA-23-positive result only for A. radioresistens strain CIP103788 (renamed strain 1 in this study), as it was the single representative of that species among the 50 isolates corresponding to the 14 Acinetobacter species tested. Additional PCRs were subsequently performed with four A. radioresistens clinical isolates (strains 2 to 5). These isolates also gave positive results; and sequencing identified an identical blaOXA-23 gene in two cases (strains 3 and 5) and very closely related genes, namely, blaOXA-103, blaOXA-102, and blaOXA-105, in strains 1, 2, and 4, respectively. Those variants had up to six amino acid substitutions compared to the sequence of β-lactamase OXA-23 (Fig. 2).


Figure 2
View larger version (16K):
[in this window]
[in a new window]

  		FIG. 2. Comparison of the amino acid sequences of the OXA-23-like determinants. OXA-23 is from A. radioresistens isolates 3 and 5, OXA-102 is from isolate 1, OXA-103 is from isolate 2, and OXA-105 is from isolate 4. Dashes indicate identical amino acid residues, and the critical motifs for CHDLs are shaded in gray. The numbering is according to the nomenclature for CHDLs (8).

Analysis of I-CeuI-restricted fragments by PFGE followed by their hybridization showed that the A. radioresistens strains gave a single fragment that cohybridized with both 16S RNA- and blaOXA-23-specific probes, demonstrating that the blaOXA-23-like genes were located on the chromosome (Fig. 3). PCR mapping indicated that the gene coding for a putative ATPase and located downstream of the acquired blaOXA-23 gene (and part of Tn2006 and Tn2007) in A. baumannii was also identified at the exact same downstream position in all five A. radioresistens strains. The corresponding proteins also displayed high degrees of amino acid identity (more than 98% amino acid identity, with no more than four nucleotide substitutions in the gene). A PCR screening of the five A. radioresistens strains for ISAba1- or ISAba4-like elements gave negative results, indicating that A. radioresistens was not a reservoir for these insertion sequence elements involved in the mobilization of blaOXA-23.


Figure 3
View larger version (85K):
[in this window]
[in a new window]

  		FIG. 3. PFGE profiles of I-Ceu-I digested whole-cell DNAs of A. radioresistens strains. Lanes 1, A. radioresistens reference strain 1; lanes 2, A. radioresistens clinical isolate 2; lanes 3, A. baumannii Ab13 isolate harboring a plasmid-located blaOXA-23 gene. Southern hybridization was performed with an internal probe specific for the blaOXA-23 gene (A) and with a probe specific for the 16S-23S rRNA gene (B). Horizontal arrows indicate the positions of hybridization with the blaOXA-23 probe. By comparison of the two hybridization patterns, cohybridizations were obtained for strains 1 and 2 (chromosomal location of blaOXA-23), whereas the blaOXA-23-positive signal obtained for A. baumannii Ab13 has no corresponding band with the 16S-23S rRNA-specific probe.

Susceptibility patterns. Antibiotic susceptibility testing showed that the five A. radioresistens were fully susceptible to all antibiotics tested, including penicillins and carbapenems. It is therefore likely that the blaOXA-23-like genes were not expressed (or were expressed at a very low level) in their host (data not shown).

Catalytic properties of OXA-23-like oxacillinases. In order to assess whether the A. radioresistens isolates expressed any carbapenemase activity, the β-lactamase activities were determined by using crude enzyme extracts of the cultures of each isolate. No hydrolysis was detected with any of these extracts obtained from the A. radioresistens strains with either benzylpenicillin or imipenem as the substrate, whereas the hydrolysis rates for A. baumannii Ab13 producing OXA-23 obtained with those two substrates were 5 and 0.2 U/mg of protein, respectively. This result further indicated a very weak expression of those naturally occurring blaOXA-23-like genes in A. radioresistens. In order to evaluate the hydrolysis profile of the newly identified OXA-23-like β-lactamases, the blaOXA-23, blaOXA-102, blaOXA-103, and blaOXA-105 genes were cloned into the same plasmid vector and expressed in E. coli under the control of the same promoter. The MICs of the β-lactams were very similar, with a slight variability of the MICs of the carbapenems (Table 2). Three- to fourfold increases in the MICs of ertapenem and meropenem were detected for OXA-102, OXA-103, and OXA-105 producers compared to the MICs for the OXA-23 producers. Further detailed kinetic analysis would be necessary to analyze those catalytic properties.


View this table:
[in this window]
[in a new window]

  		TABLE 2. MICs of carbapenems for the E. coli TOP10 recombinant strains expressing OXA-23, OXA-102, OXA-103, and OXA-105 and reference strain E. coli TOP10

Plasmid analysis. The repAci1 gene, which encodes a replicase, was recently identified as part of the replication control system of plasmids carrying blaOXA-58 (another acquired CHDL-encoding gene from A. baumannii) (3). The blaOXA-23-positive A. baumannii and A. radioresistens strains were evaluated to determine whether they carry plasmids with the repAci1 gene. These repAci1-positive plasmids may have a restricted host range since they did not replicate in members of the family Enterobacteriaceae (3, 13, 32). Our hypothesis was that this plasmid type could be also the vehicle for the dissemination of blaOXA-23 and may thus be present in A. baumannii as the recipient and possibly in A. radioresistens as the donor. A preliminary screening of 15 blaOXA-23-positive A. baumannii isolates collected worldwide showed that the repAci1 plasmids were identified in eight of these isolates, which in some cases also harbored the blaOXA-23 gene (unpublished data). A similar screening performed with the A. radioresistens strains analyzed in this study identified repAci1 plasmids in a single strain. Thus, plasmids with an identical origin of replication were identified in A. radioresistens and A. baumannii.


arrow
DISCUSSION
 
We found in the present study that A. radioresistens is the progenitor of the blaOXA-23-like genes currently emerging as the sources of carbapenem resistance in A. baumannii worldwide. This statement is based on the identification on the A. radioresistens chromosome of genes encoding both OXA-23-like and ATPase-like enzymes, with those genes being located near each other. The way in which the blaOXA-23 gene has been mobilized from A. radioresistens and has disseminated to A. baumannii might correspond to the following model. A plasmid-mediated ISAba1 element originating from A. baumannii may enter A. radioresistens and then transpose and target the regions upstream and downstream of the chromosomal blaOXA-23-like gene, thus forming a transposon-like structure and also enhancing the expression of the blaOXA-23-like gene. This structure may then transpose and target a plasmid inside the A. radioresistens genome, and finally, this plasmid conjugates into A. baumannii, thus spreading the resistance determinant in the latter species.

A. radioresistens is a commensal species of the skin of healthy individuals (2, 36) and hospitalized patients (36, 43). The virulence role of that bacterium may be limited, since only one case of bacteremia has been reported so far and occurred in a human immunodeficiency virus-positive immunodepressed patient (41). However, the precise identification of Acinetobacter sp. isolates at the species level is not easy, and the use of molecular tools is required for unambiguous identification. It could therefore be possible that the true pathogenic trait of A. radioresistens might be underestimated, with many Acinetobacter sp.-related infections actually being due to A. radioresistens.

The A. radioresistens isolates studied were fully susceptible to β-lactams, indicating that the blaOXA-23-like genes are likely poorly expressed from their original hosts. This indicates, as underlined by Iredell and Sintchenko (17), that the control of the reservoir of resistance genes might be more complex than expected. The source of the resistance gene may remain hidden, since it is located in a bacterial species that is not searched for in hospital settings and that is known to be highly resistant to desiccation and radiation (5, 18).

It is possible that genetic exchange between the progenitor (A. radioresistens) and its recipient of clinical relevance (A. baumannii), which leads to carbapenem resistance in the latter species, may have occurred in humans. Taking into account the fact that both A. baumannii and A. radioresistens are identified on the human skin, especially in hospitalized patients, it is possible that blaOXA-23 gene exchange may occur at that location (2, 36).

A. radioresistens may be more prevalent than expected in the hospital environment, since it has been identified as the most common Acinetobacter species in hospital environmental samples (43). The identification of same plasmid types in A. radioresistens and A. baumannii further strengthens the possibility of gene exchange between those two species.

This study identified the source of an acquired and clinically relevant resistance gene. The unambiguous identification of the reservoir (origin) of an acquired resistance gene, such as blaSHV from Klebsiella pneumoniae (39), the emerging blaCTX-M-like genes from Kluyvera ascorbata and Kluyvera georgiana (16, 27), the plasmid-mediated cephalosporinase genes from several gram-negative species (26), and the plasmid-mediated qnrA gene from Shewanella algae (30), has very rarely been reported. Our findings further emphasize the possible role of the hospital environment as a reservoir of antibiotic resistance genes and a place where gene exchange may occur. The future control of multidrug resistance may necessitate identification of not only the multidrug-resistant isolates but also their reservoirs by molecular-based techniques.


arrow
ACKNOWLEDGMENTS
 
This work was funded by a grant from the Ministère de l'Education Nationale et de la Recherche (grant UPRES-EA3539), Université Paris XI, Paris, France, and mostly by a grant from the European Community (6th PCRD, grant LSHM-CT-2005-018705). S.F. was funded by a grant-in-aid from the Fondation pour la Recherche Médicale, Paris, France.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Service de Bactériologie-Virologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, Le Kremlin-Bicêtre 94275, France. Phone: 33-1-45-21-36-32. Fax: 33-1-45-21-63-40. E-mail: nordmann.patrice{at}bct.aphp.fr Back

{triangledown} Published ahead of print on 14 January 2008. Back


arrow
REFERENCES
 
    1
  1. Barbe, V., D. Vallenet, N. Fonknechten, A. Kreimeyer, S. Oztas, L. Labarre, S. Cruveiller, C. Robert, S. Duprat, P. Wincker, L. N. Ornston, J. Weissenbach, P. Marliere, G. N. Cohen, and C. Medigue. 2004. Unique features revealed by the genome sequence of Acinetobacter sp. ADP1, a versatile and naturally transformation competent bacterium. Nucleic Acids Res. 32:5766-5779.[Abstract/Free Full Text]
    2. 2
  2. Berlau, J., H. Aucken, H. Malnick, and T. Pitt. 1999. Distribution of Acinetobacter species on skin of healthy humans. Eur. J. Clin. Microbiol. Infect. Dis. 18:179-183.[CrossRef][Medline]
    3. 3
  3. Bertini, A., L. Poirel, S. Bernabeu, D. Fortini, L. Villa, P. Nordmann, and A. Carattoli. 2007. Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:2324-2328.[Abstract/Free Full Text]
    4. 4
  4. Bonomo, R. A., and D. Szabo. 2006. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin. Infect. Dis. 43(Suppl. 2):S49-S56.[CrossRef][Medline]
    5. 5
  5. Christensen, E. A., P. Gerner-Smidt, and H. Kristensen. 1991. Radiation resistance of clinical Acinetobacter spp.: a need for concern? J. Hosp. Infect. 18:85-92.[Medline]
    6. 6
  6. Coelho, J. M., J. F. Turton, M. E. Kaufmann, J. Glover, N. Woodford, M. Warner, M. F. Palepou, R. Pike, T. L. Pike, B. C. Patel, and D. M. Livermore. 2006. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and southeast England. J. Clin. Microbiol. 44:3623-3627.[Abstract/Free Full Text]
    7. 7
  7. Corvec, S., L. Poirel, T. Naas, H. Drugeon, and P. Nordmann. 2007. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:1530-1533.[Abstract/Free Full Text]
    8. 8
  8. Couture, F., J. Lachapelle, and R. C. Lévesque. 1992. Phylogeny of LCR-1 and OXA-5 with class A and class D β-lactamases. Mol. Microbiol. 6:1693-1705.[Medline]
    9. 9
  9. Dalla-Costa, L. M., J. M. Coelho, H. A. Souza, M. E. Castro, C. J. Stier, K. L. Bragagnolo, A. Rea-Neto, S. R. Penteado-Filho, D. M. Livermore, and N. Woodford. 2003. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J. Clin. Microbiol. 41:3403-3406.[Abstract/Free Full Text]
    10. 10
  10. Donald, H. M., W. Scaife, S. G. Amyes, and H. K. Young. 2000. Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob. Agents Chemother. 44:196-199.[Abstract/Free Full Text]
    11. 11
  11. Dortet, L., P. Legrand, C. J. Soussy, and V. Cattoir. 2006. Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J. Clin. Microbiol. 44:4471-4478.[Abstract/Free Full Text]
    12. 12
  12. Fournier, P. E., D. Vallenet, V. Barbe, S. Audic, H. Ogata, L. Poirel, H. Richet, C. Robert, S. Mangenot, C. Abergel, P. Nordmann, J. Weissenbach, D. Raoult, and J. M. Claverie. 2006. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2:e7.[CrossRef][Medline]
    13. 13
  13. Héritier, C., L. Poirel, T. Lambert, and P. Nordmann. 2005. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:3198-3202.[Abstract/Free Full Text]
    14. 14
  14. Héritier, C., L. Poirel, and P. Nordmann. 2006. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect. 12:123-130.[CrossRef][Medline]
    15. 15
  15. Hujer, K. M., A. M. Hujer, E. A. Hulten, S. Bajaksouzian, J. M. Adams, C. J. Donskey, D. J. Ecker, C. Massire, M. W. Eshoo, R. Sampath, J. M. Thomson, P. N. Rather, D. W. Craft, J. T. Fishbai, A. J. Ewell, M. R. Jacobs, D. L. Paterson, and R. A. Bonomo. 2006. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother. 50:4114-4123.
    16. 16
  16. Humeniuk, C., G. Arlet, V. Gautier, P. Grimont, R. Labia, and A. Philippon. 2002. β-Lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob. Agents Chemother. 46:3045-3049.[Abstract/Free Full Text]
    17. 17
  17. Iredell, J. R., and V. Sintchenko. 2006. Screening for antibiotic resistant gram-negative bacteria. Lancet Infect. Dis. 6:316-317.[CrossRef][Medline]
    18. 18
  18. Jawad, A., A. M. Snelling, J. Heritage, and P. M. Hawkey. 1998. Exceptional desiccation tolerance of Acinetobacter radioresistens. J. Hosp. Infect. 39:235-240.[CrossRef][Medline]
    19. 19
  19. Jeong, S. H., I. K. Bae, K. O. Park, Y. J. An, S. G. Sohn, S. J. Jang, K. H. Sung, K. S. Yang, K. Lee, D. Young, and S. H. Lee. 2006. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J. Microbiol. 44:423-431.[Medline]
    20. 20
  20. Jones, A., D. Morgan, A. Walsh, J. Turton, D. Livermore, T. Pitt, A. Green, M. Gill, and D. Mortiboy. 2006. Importation of multidrug-resistant Acinetobacter spp. infections with casualties from Iraq. Lancet Infect. Dis. 6:317-318.[CrossRef][Medline]
    21. 21
  21. Liu, S. L., A. Hessel, and K. E. Sanderson. 1993. Genomic mapping with I-Ceu-I, an intron-encoded endonuclease specific for genes for ribosomal RNA in Salmonella spp., Escherichia coli, and other bacteria. Proc. Natl. Acad. Sci. USA 90:6874-6878.[Abstract/Free Full Text]
    22. 22
  22. Mammeri, H., L. Poirel, N. Mangeney, and P. Nordmann. 2003. Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to β-lactams. Antimicrob. Agents Chemother. 47:1536-1542.[Abstract/Free Full Text]
    23. 23
  23. Naas, T., M. Levy, C. Hirschauer, H. Marchandin, and P. Nordmann. 2005. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J. Clin. Microbiol. 43:4826-4829.[Abstract/Free Full Text]
    24. 24
  24. Nishimura, Y., H. Kanzaki, and H. Izuka. 1988. Taxonomic studies of Acinetobacter species on the electrophoretic analysis of enzymes. J. Basic Microbiol. 28:363-370.[CrossRef][Medline]
    25. 25
  25. Perez, F., A. M. Hujer, K. M. Hujer, B. K. Decker, P. N. Rather, and R. A. Bonomo. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:3471-3484.[Free Full Text]
    26. 26
  26. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.[Free Full Text]
    27. 27
  27. Poirel, L., P. Kämpfer, and P. Nordmann. 2002. Chromosome-encoded Ambler class A β-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 46:4038-4040.[Abstract/Free Full Text]
    28. 28
  28. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836.[CrossRef][Medline]
    29. 29
  29. Poirel, L., O. Menuteau, N. Agoli, C. Cattoen, and P. Nordmann. 2003. Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol. 41:3542-3547.[Abstract/Free Full Text]
    30. 30
  30. Poirel, L., J. M. Rodriguez-Martinez, H. Mammeri, A. Liard, and P. Nordmann. 2005. Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob. Agents Chemother. 49:3523-3525.[Abstract/Free Full Text]
    31. 31
  31. Poirel, L., M. Guibert, D. Girlich, T. Naas, and P. Nordmann. 1999. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrob. Agents Chemother. 43:769-776.[Abstract/Free Full Text]
    32. 32
  32. Poirel, L., S. Marqué, C. Héritier, C. Segonds, G. Chabanon, and P. Nordmann. 2005. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:202-208.[Abstract/Free Full Text]
    33. 33
  33. Quale, J., S. Bratu, D. Landman, and R. Heddurshetti. 2003. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin. Infect. Dis. 37:214-220.[CrossRef][Medline]
    34. 34
  34. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
    35. 35
  35. Segal, H., S. Garny, and B. G. Elisha. 2005. Is ISAba1 customized for Acinetobacter? FEMS Microbiol. Lett. 243:425-429.[CrossRef][Medline]
    36. 36
  36. Seifert, H., L. Dijkshoorn, P. Gerner-Smidt, N. Pelzer, I. Tjernberg, and M. Vaneechoutte. 1997. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J. Clin. Microbiol. 35:2819-2825.[Abstract]
    37. 37
  37. Smith, M. G., T. A. Gianoulis, S. Pukatzki, J. J. Mekalanos, L. N. Ornston, M. Gerstein, and M. Snyder. 2007. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 21:601-614.[Abstract/Free Full Text]
    38. 38
  38. Thomson, J. M., and R. A. Bonomo. 2005. The threat of antibiotic resistance in gram-negative pathogenic bacteria: β-lactams in peril! Curr. Opin. Microbiol. 8:518-524.[CrossRef][Medline]
    39. 39
  39. Tzouvelekis, L. S., and R. A. Bonomo. 1999. SHV-type β-lactamases. Curr. Pharm. Des. 5:847-864.[Medline]
    40. 40
  40. Villegas, M. V., J. N. Kattan, A. Correa, K. Lolans, A. M. Guzman, N. Woodford, D. Livermore, and J. P. Quinn. 2007. Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals. Antimicrob. Agents Chemother. 51:2001-2004.[Abstract/Free Full Text]
    41. 41
  41. Visca, P., A. Petrucca, P. De Mori, A. Festa, E. Boumis, A. Antinori, and N. Petrosillo. 2001. Community-acquired Acinetobacter radioresistens bacteremia in an HIV-positive patient. Emerg. Infect. Dis. 7:1032-1035.[Medline]
    42. 42
  42. Wang, H., P. Guo, H. Sun, H. Wang, Q. Yang, M. Chen, Y. Xu, and Y. Zhu. 2007. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob. Agents Chemother. 51:4022-4028.
    43. 43
  43. Webster, C. A., M. Crowe, H. Humphreys, and K. J. Towner. 1998. Surveillance of an adult intensive care unit for long-term persistence of a multi-resistant strain of Acinetobacter baumannii. Eur. J. Clin. Microbiol. Infect. Dis. 17:171-176.[Medline]
    44. 44
  44. Zhou, H., B. R. Pi, Q. Yang, Y. S. Yu, Y. G. Chen, L. J. Li, and S. S. Zheng. 2007. Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1 blaOXA-23 genes in a Chinese hospital. J. Med. Microbiol. 56:1076-1080.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, April 2008, p. 1252-1256, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.01304-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Higgins, P. G., Poirel, L., Lehmann, M., Nordmann, P., Seifert, H. (2009). OXA-143, a Novel Carbapenem-Hydrolyzing Class D {beta}-Lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53: 5035-5038 [Abstract] [Full Text]  
  • Livermore, D. M. (2009). Has the era of untreatable infections arrived?. J Antimicrob Chemother 64: i29-i36 [Abstract] [Full Text]  
  • Boo, T. W., Crowley, B. (2009). Detection of blaOXA-58 and blaOXA-23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned?. J Med Microbiol 58: 839-841 [Full Text]  
  • Mendes, R. E., Bell, J. M., Turnidge, J. D., Castanheira, M., Deshpande, L. M., Jones, R. N. (2009). Codetection of blaOXA-23-Like Gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 53: 843-844 [Full Text]  
  • Mendes, R. E., Bell, J. M., Turnidge, J. D., Castanheira, M., Jones, R. N. (2009). Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 63: 55-59 [Abstract] [Full Text]  
  • Adams-Haduch, J. M., Paterson, D. L., Sidjabat, H. E., Pasculle, A. W., Potoski, B. A., Muto, C. A., Harrison, L. H., Doi, Y. (2008). Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania. Antimicrob. Agents Chemother. 52: 3837-3843 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poirel, L.
Right arrow Articles by Nordmann, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poirel, L.
Right arrow Articles by Nordmann, P.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»